In a Q&A, Peter Monti, a professor of alcohol and addiction studies at Brown University and a leading researcher of alcohol and disease exacerbation, shared his perspective on alcohol and cancer.

With renewed funding from the National Institutes of Health, the Center for Addiction and Disease Risk Exacerbation will build on its research to understand mechanisms linking substance use with chronic disease.

A team of Brown faculty members is conducting the first study of its kind to investigate whether MDMA-assisted therapy can relieve the suffering of Veterans with PTSD and alcohol use disorder.

Post traumatic stress disorder (PTSD) is among the most common conditions facing U.S. Veterans, with no effective cure. Additionally, many Veterans use alcohol to alleviate their trauma, making medical treatment even more complex. For these high risk patients, Professors Christy Capone and Carolina Haass-Koffler are thinking outside the box: Could a treatment involving psychedelic drugs potentially save Veteran lives?

Over his 50 years at Brown University, Professor Peter M. Monti has not only been witness to a sea change in our understanding of addictive disorders, but has contributed to that understanding with his research and leadership. At the School of Public Health’s 10th anniversary, he reflects on the decades of work defining Brown’s public health legacy.

Faculty members at the School of Public Health will use a Brown Research Seed Award to evaluate MDMA’s potential as treatment for veterans with co-occurring PTSD and alcohol use disorder.

Safety, feasibility, and acceptability of MDMA-assisted therapy for the treatment of co-occurring alcohol use disorders and posttraumatic stress disorder in veterans.

With a new five-year grant from the National Institutes of Health, the Center for Addiction and Disease Risk Exacerbation will launch four research projects and establish a clinical laboratory for biological addiction research at Brown University.